Copyright Reports & Markets. All rights reserved.

Global Heart Defect Closure Device Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Heart Defect Closure Device Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Heart Defect Closure Device Market Size Growth Rate by Product
      • 1.4.2 ASD Closure Devices
      • 1.4.3 VSD Closure Devices
      • 1.4.4 PDA Closure Devices
      • 1.4.5 PFO Closure Devices
      • 1.4.6 LAA Closure Devices
    • 1.5 Market by End User
      • 1.5.1 Global Heart Defect Closure Device Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Heart Defect Closure Device Market Size
      • 2.1.1 Global Heart Defect Closure Device Revenue 2014-2025
      • 2.1.2 Global Heart Defect Closure Device Sales 2014-2025
    • 2.2 Heart Defect Closure Device Growth Rate by Regions
      • 2.2.1 Global Heart Defect Closure Device Sales by Regions
      • 2.2.2 Global Heart Defect Closure Device Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Heart Defect Closure Device Sales by Manufacturers
      • 3.1.1 Heart Defect Closure Device Sales by Manufacturers
      • 3.1.2 Heart Defect Closure Device Sales Market Share by Manufacturers
      • 3.1.3 Global Heart Defect Closure Device Market Concentration Ratio (CR5 and HHI)
    • 3.2 Heart Defect Closure Device Revenue by Manufacturers
      • 3.2.1 Heart Defect Closure Device Revenue by Manufacturers (2014-2019)
      • 3.2.2 Heart Defect Closure Device Revenue Share by Manufacturers (2014-2019)
    • 3.3 Heart Defect Closure Device Price by Manufacturers
    • 3.4 Heart Defect Closure Device Manufacturing Base Distribution, Product Types
      • 3.4.1 Heart Defect Closure Device Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Heart Defect Closure Device Product Type
      • 3.4.3 Date of International Manufacturers Enter into Heart Defect Closure Device Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Heart Defect Closure Device Sales by Product
    • 4.2 Global Heart Defect Closure Device Revenue by Product
    • 4.3 Heart Defect Closure Device Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Heart Defect Closure Device Breakdown Data by End User

    6 North America

    • 6.1 North America Heart Defect Closure Device by Countries
      • 6.1.1 North America Heart Defect Closure Device Sales by Countries
      • 6.1.2 North America Heart Defect Closure Device Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Heart Defect Closure Device by Product
    • 6.3 North America Heart Defect Closure Device by End User

    7 Europe

    • 7.1 Europe Heart Defect Closure Device by Countries
      • 7.1.1 Europe Heart Defect Closure Device Sales by Countries
      • 7.1.2 Europe Heart Defect Closure Device Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Heart Defect Closure Device by Product
    • 7.3 Europe Heart Defect Closure Device by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Heart Defect Closure Device by Countries
      • 8.1.1 Asia Pacific Heart Defect Closure Device Sales by Countries
      • 8.1.2 Asia Pacific Heart Defect Closure Device Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Heart Defect Closure Device by Product
    • 8.3 Asia Pacific Heart Defect Closure Device by End User

    9 Central & South America

    • 9.1 Central & South America Heart Defect Closure Device by Countries
      • 9.1.1 Central & South America Heart Defect Closure Device Sales by Countries
      • 9.1.2 Central & South America Heart Defect Closure Device Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Heart Defect Closure Device by Product
    • 9.3 Central & South America Heart Defect Closure Device by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Heart Defect Closure Device by Countries
      • 10.1.1 Middle East and Africa Heart Defect Closure Device Sales by Countries
      • 10.1.2 Middle East and Africa Heart Defect Closure Device Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Heart Defect Closure Device by Product
    • 10.3 Middle East and Africa Heart Defect Closure Device by End User

    11 Company Profiles

    • 11.1 Abbott
      • 11.1.1 Abbott Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Heart Defect Closure Device Products Offered
      • 11.1.5 Abbott Recent Development
    • 11.2 Boston Scientific
      • 11.2.1 Boston Scientific Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Boston Scientific Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Boston Scientific Heart Defect Closure Device Products Offered
      • 11.2.5 Boston Scientific Recent Development
    • 11.3 LifeTech
      • 11.3.1 LifeTech Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 LifeTech Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 LifeTech Heart Defect Closure Device Products Offered
      • 11.3.5 LifeTech Recent Development
    • 11.4 Lepu Medical
      • 11.4.1 Lepu Medical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Lepu Medical Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Lepu Medical Heart Defect Closure Device Products Offered
      • 11.4.5 Lepu Medical Recent Development
    • 11.5 Occlutech
      • 11.5.1 Occlutech Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Occlutech Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Occlutech Heart Defect Closure Device Products Offered
      • 11.5.5 Occlutech Recent Development
    • 11.6 W. L. Gore & Associates
      • 11.6.1 W. L. Gore & Associates Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 W. L. Gore & Associates Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 W. L. Gore & Associates Heart Defect Closure Device Products Offered
      • 11.6.5 W. L. Gore & Associates Recent Development
    • 11.7 Starway
      • 11.7.1 Starway Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Starway Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Starway Heart Defect Closure Device Products Offered
      • 11.7.5 Starway Recent Development
    • 11.8 Coherex Medical
      • 11.8.1 Coherex Medical Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Coherex Medical Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Coherex Medical Heart Defect Closure Device Products Offered
      • 11.8.5 Coherex Medical Recent Development
    • 11.9 Cardia
      • 11.9.1 Cardia Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Cardia Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Cardia Heart Defect Closure Device Products Offered
      • 11.9.5 Cardia Recent Development
    • 11.10 MicroPort
      • 11.10.1 MicroPort Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 MicroPort Heart Defect Closure Device Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 MicroPort Heart Defect Closure Device Products Offered
      • 11.10.5 MicroPort Recent Development

    12 Future Forecast

    • 12.1 Heart Defect Closure Device Market Forecast by Regions
      • 12.1.1 Global Heart Defect Closure Device Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Heart Defect Closure Device Revenue Forecast by Regions 2019-2025
    • 12.2 Heart Defect Closure Device Market Forecast by Product
      • 12.2.1 Global Heart Defect Closure Device Sales Forecast by Product 2019-2025
      • 12.2.2 Global Heart Defect Closure Device Revenue Forecast by Product 2019-2025
    • 12.3 Heart Defect Closure Device Market Forecast by End User
    • 12.4 North America Heart Defect Closure Device Forecast
    • 12.5 Europe Heart Defect Closure Device Forecast
    • 12.6 Asia Pacific Heart Defect Closure Device Forecast
    • 12.7 Central & South America Heart Defect Closure Device Forecast
    • 12.8 Middle East and Africa Heart Defect Closure Device Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Heart Defect Closure Device Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.
      The classification of Heart Defect Closure Devices includes ASD Closure Devices, VSD Closure Devices, PDA Closure Devices, PFO Closure Devices and LAA Closure Devices. And the proportion of Amplatzer PFO Occluder in 2017 is about 33%, and the proportion is in decreasing trend from 2013 to 2017. LAA Closure Devices with the growth rate about 18%, in 2017 the market share is nearly 22%.
      Heart Defect Closure Devices is widely used in hospitals and clinics. The most proportion of Heart Defect Closure Devices is used in Hospital, and the proportion in 2017 is 61%.
      Europe is the largest consumption place, with a consumption market share nearly 30% in 2017. Following Europe, North America is the second largest consumption place with the consumption market share of 27%.
      The global Heart Defect Closure Device market is valued at 590 million US$ in 2018 and will reach 1250 million US$ by the end of 2025, growing at a CAGR of 9.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Heart Defect Closure Device market based on company, product type, end user and key regions.

      This report studies the global market size of Heart Defect Closure Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Heart Defect Closure Device in these regions.
      This research report categorizes the global Heart Defect Closure Device market by top players/brands, region, type and end user. This report also studies the global Heart Defect Closure Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Abbott
      Boston Scientific
      LifeTech
      Lepu Medical
      Occlutech
      W. L. Gore & Associates
      Starway
      Coherex Medical
      Cardia
      MicroPort

      Market size by Product
      ASD Closure Devices
      VSD Closure Devices
      PDA Closure Devices
      PFO Closure Devices
      LAA Closure Devices
      Market size by End User
      Hospitals
      Clinics
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Heart Defect Closure Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Heart Defect Closure Device market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Heart Defect Closure Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Heart Defect Closure Device submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Heart Defect Closure Device are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Heart Defect Closure Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now